Literature DB >> 1587826

Kinetics and regulation of hepatoma mitochondrial NAD(P) malic enzyme.

J K Teller1, L A Fahien, J W Davis.   

Abstract

Kinetic studies of Morris 7777 hepatoma mitochondrial NAD(P) malic enzyme were consistent with an ordered mechanism where NAD adds to the enzyme before malate and dissociation of NADH from the enzyme is rate-limiting. In addition to its active site, malate apparently also associates with a lower affinity with an activator site. The activator fumarate competes with malate at the activator site and facilitates dissociation of NADH from the enzyme. The ratio of NAD(P) malic enzyme to malate dehydrogenase activity in the hepatoma mitochondrial extract was found to be too low, even in the presence of known inhibitors of malate dehydrogenase, to account for the known ability of NAD(P) malic enzyme to intercept exogenous malate from malate dehydrogenase in intact tumor mitochondria (Moreadith, R.W., and Lehninger, A.L. (1984) J. Biol. Chem. 259, 6215-6221). However, NAD(P) malic enzyme may be able to intercept exogenous malate because according to the present results, it can associate with the pyruvate dehydrogenase complex, which could localize NAD(P) malic enzyme in the vicinity of the inner mitochondrial membrane. The activity levels of some key metabolic enzymes were found to be different in Morris 7777 mitochondria than in liver or mitochondria of other rapidly dividing tumors. These results are discussed in terms of differences among tumors in their ability to utilize malate, glutamate, and citrate as respiratory fuels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587826

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Characterization of the functional role of allosteric site residue Asp102 in the regulatory mechanism of human mitochondrial NAD(P)+-dependent malate dehydrogenase (malic enzyme).

Authors:  Hui-Chih Hung; Meng-Wei Kuo; Gu-Gang Chang; Guang-Yaw Liu
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

2.  Nonidentity of the cDNA sequence of human breast cancer cell malic enzyme to that from the normal human cell.

Authors:  W Y Chou; S M Huang; G G Chang
Journal:  J Protein Chem       Date:  1996-04

3.  Mitochondrial malic enzyme (ME2) in pancreatic islets of the human, rat and mouse and clonal insulinoma cells.

Authors:  Michael J MacDonald; Melissa J Longacre; Mindy A Kendrick
Journal:  Arch Biochem Biophys       Date:  2009-08-15       Impact factor: 4.013

4.  Investigating the roles of mitochondrial and cytosolic malic enzyme in insulin secretion.

Authors:  Rebecca L Pongratz; Richard G Kibbey; Gary W Cline
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

5.  Mitochondrial dysfunction contributes to impaired insulin secretion in INS-1 cells with dominant-negative mutations of HNF-1alpha and in HNF-1alpha-deficient islets.

Authors:  Rebecca L Pongratz; Richard G Kibbey; Clare L Kirkpatrick; Xiaojian Zhao; Marco Pontoglio; Moshe Yaniv; Claes B Wollheim; Gerald I Shulman; Gary W Cline
Journal:  J Biol Chem       Date:  2009-04-17       Impact factor: 5.157

6.  Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.

Authors:  Aimee E Vozenilek; Matthew Vetkoetter; Jonette M Green; Xinggui Shen; James G Traylor; Ronald L Klein; A Wayne Orr; Matthew D Woolard; David M Krzywanski
Journal:  J Vasc Res       Date:  2018-02-16       Impact factor: 1.934

7.  Functional roles of the tetramer organization of malic enzyme.

Authors:  Ju-Yi Hsieh; Shao-Hung Chen; Hui-Chih Hung
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

8.  Fuel-Stimulated Insulin Secretion Depends upon Mitochondria Activation and the Integration of Mitochondrial and Cytosolic Substrate Cycles.

Authors:  Gary W Cline
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

9.  Large-scale genome-wide association studies and meta-analyses of longitudinal change in adult lung function.

Authors:  Wenbo Tang; Matthew Kowgier; Daan W Loth; María Soler Artigas; Bonnie R Joubert; Emily Hodge; Sina A Gharib; Albert V Smith; Ingo Ruczinski; Vilmundur Gudnason; Rasika A Mathias; Tamara B Harris; Nadia N Hansel; Lenore J Launer; Kathleen C Barnes; Joyanna G Hansen; Eva Albrecht; Melinda C Aldrich; Michael Allerhand; R Graham Barr; Guy G Brusselle; David J Couper; Ivan Curjuric; Gail Davies; Ian J Deary; Josée Dupuis; Tove Fall; Millennia Foy; Nora Franceschini; Wei Gao; Sven Gläser; Xiangjun Gu; Dana B Hancock; Joachim Heinrich; Albert Hofman; Medea Imboden; Erik Ingelsson; Alan James; Stefan Karrasch; Beate Koch; Stephen B Kritchevsky; Ashish Kumar; Lies Lahousse; Guo Li; Lars Lind; Cecilia Lindgren; Yongmei Liu; Kurt Lohman; Thomas Lumley; Wendy L McArdle; Bernd Meibohm; Andrew P Morris; Alanna C Morrison; Bill Musk; Kari E North; Lyle J Palmer; Nicole M Probst-Hensch; Bruce M Psaty; Fernando Rivadeneira; Jerome I Rotter; Holger Schulz; Lewis J Smith; Akshay Sood; John M Starr; David P Strachan; Alexander Teumer; André G Uitterlinden; Henry Völzke; Arend Voorman; Louise V Wain; Martin T Wells; Jemma B Wilk; O Dale Williams; Susan R Heckbert; Bruno H Stricker; Stephanie J London; Myriam Fornage; Martin D Tobin; George T O'Connor; Ian P Hall; Patricia A Cassano
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

10.  A small-molecule inhibitor suppresses the tumor-associated mitochondrial NAD(P)+-dependent malic enzyme (ME2) and induces cellular senescence.

Authors:  Ju-Yi Hsieh; Shao-Yu Li; Wen-Chen Tsai; Jyung-Hurng Liu; Chih-Li Lin; Guang-Yaw Liu; Hui-Chih Hung
Journal:  Oncotarget       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.